Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Alimera Sciences (ALIM) has a market cap of $0.30 billion USD. According to our data, Alimera Sciences is ranked No.6686 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Sep 18, 2024 | $0.30 B |
28.24%
|
| Dec 29, 2023 | $0.23 B |
59.41%
|
| Dec 30, 2022 | $0.15 B |
-47.17%
|
| Dec 31, 2021 | $0.28 B |
21.56%
|
| Dec 31, 2020 | $0.23 B |
-44.33%
|
| Dec 31, 2019 | $0.41 B |
-29.63%
|
| Dec 31, 2018 | $0.59 B |
-46.01%
|
| Dec 29, 2017 | $1.08 B |
23.15%
|
| Dec 30, 2016 | $0.88 B |
-55.37%
|
| Dec 31, 2015 | $1.97 B |
-56.32%
|
| Dec 31, 2014 | $4.52 B |
17.87%
|
| Dec 31, 2013 | $3.83 B |
199.36%
|
| Dec 31, 2012 | $1.28 B |
25.60%
|
| Dec 30, 2011 | $1.02 B |
-87.96%
|
| Dec 31, 2010 | $8.47 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
 Novartis
NVS
|
$196.25 B |
0.003 M
|
Switzerland
|
 Bausch Health
BHC
|
$2.85 B |
6.423 M
|
Canada
|
 EyePoint Pharmaceuticals
EYPT
|
$0.60 B |
-0.000 M
|
USA
|
 Ocular Therapeutix
OCUL
|
$1.26 B |
-0.000 M
|
USA
|
 Kodiak Sciences
KOD
|
$0.42 B |
-0.000 M
|
USA
|
 Adverum Biotechnologies
ADVM
|
$92.99 M |
-0.000 M
|
USA
|
 Outlook Therapeutics
OTLK
|
$52.05 M |
-0.000 M
|
USA
|
 Clearside Biomedical
CLSD
|
$72.42 M |
-0.000 M
|
USA
|
| Market Cap | = | ALIM Stock Price | * | ALIM Shares Outstanding |
| = | $5.54 | * | 54.38 M | |
| = | $0.30 B |